Antiandrogen treatments in locally advanced prostate cancer: are they all the same?

  title={Antiandrogen treatments in locally advanced prostate cancer: are they all the same?},
  author={D. Gillatt},
  journal={Journal of Cancer Research and Clinical Oncology},
  • D. Gillatt
  • Published 2006
  • Medicine
  • Journal of Cancer Research and Clinical Oncology
  • PurposeThe objectives are to review the published literature and to evaluate the weight of evidence for clinical effectiveness, safety, and tolerability of the currently available antiandrogens in the treatment of locally advanced prostate cancer. This article covers efficacy as monotherapy relative to castration and as adjuvant to radiotherapy and radical prostatectomy as well as adverse-effect and quality-of-life data.MethodsThe current literature from online databases between 1986 and the… CONTINUE READING
    52 Citations
    Safety of antiandrogen therapy for treating prostate cancer
    • 14
    Treatment of bicalutamide-induced breast events
    • P. Sieber
    • Medicine
    • Expert review of anticancer therapy
    • 2007
    • 17
    [Hormonal treatment in prostate cancer].
    • 2
    • PDF
    Hormonotherapy of Bone Metastases
    Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins.
    • 38
    • Highly Influenced
    Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer.
    • 9
    • PDF
    14 Prostate Cancer : Current and Emerging Therapies


    The role of antiandrogen monotherapy in the treatment of prostate cancer
    • 108
    Nilutamide: An Antiandrogen for the Treatment of Prostate Cancer
    • 43
    Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.
    • 335
    • Highly Influential
    Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
    • 34
    • Highly Influential
    Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    • 74
    Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    • A. Chang, B. Yeap, +8 authors D. Trump
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1996
    • 113
    Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
    • 136
    • Highly Influential